BIB vs. SSO
Compare and contrast key facts about ProShares Ultra Nasdaq Biotechnology (BIB) and ProShares Ultra S&P 500 (SSO).
BIB and SSO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BIB is a passively managed fund by ProShares that tracks the performance of the NASDAQ Biotechnology Index (200%). It was launched on Apr 7, 2010. SSO is a passively managed fund by ProShares that tracks the performance of the S&P 500 Index (200%). It was launched on Jun 21, 2006. Both BIB and SSO are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIB or SSO.
Key characteristics
| BIB | SSO | |
|---|---|---|
| YTD Return | -1.21% | 18.27% |
| 1Y Return | -1.57% | 52.34% |
| 3Y Return (Ann) | -11.79% | 11.32% |
| 5Y Return (Ann) | 3.33% | 20.94% |
| 10Y Return (Ann) | 4.41% | 19.78% |
| Sharpe Ratio | 0.03 | 2.32 |
| Daily Std Dev | 33.41% | 22.98% |
| Max Drawdown | -67.24% | -84.67% |
| Current Drawdown | -49.40% | -1.03% |
Correlation
The correlation between BIB and SSO is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BIB vs. SSO - Performance Comparison
In the year-to-date period, BIB achieves a -1.21% return, which is significantly lower than SSO's 18.27% return. Over the past 10 years, BIB has underperformed SSO with an annualized return of 4.41%, while SSO has yielded a comparatively higher 19.78% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIB vs. SSO - Expense Ratio Comparison
BIB has a 0.95% expense ratio, which is higher than SSO's 0.90% expense ratio.
Risk-Adjusted Performance
BIB vs. SSO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and ProShares Ultra S&P 500 (SSO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIB vs. SSO - Dividend Comparison
BIB's dividend yield for the trailing twelve months is around 0.14%, less than SSO's 0.39% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.14% | 0.07% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SSO ProShares Ultra S&P 500 | 0.39% | 0.18% | 0.50% | 0.18% | 0.20% | 0.50% | 0.75% | 0.39% | 0.50% | 0.63% | 0.33% | 0.26% |
Drawdowns
BIB vs. SSO - Drawdown Comparison
The maximum BIB drawdown since its inception was -67.24%, smaller than the maximum SSO drawdown of -84.67%. Use the drawdown chart below to compare losses from any high point for BIB and SSO. For additional features, visit the drawdowns tool.
Volatility
BIB vs. SSO - Volatility Comparison
ProShares Ultra Nasdaq Biotechnology (BIB) has a higher volatility of 9.20% compared to ProShares Ultra S&P 500 (SSO) at 6.71%. This indicates that BIB's price experiences larger fluctuations and is considered to be riskier than SSO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.